| Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers M Cobbold, N Khan, B Pourgheysari, S Tauro, D McDonald, H Osman, ... The Journal of experimental medicine 202 (3), 379-386, 2005 | 625 | 2005 |
| Mitomycin, ifosfamide, and cisplatin in unresectable non–small-cell lung cancer: Effects on survival and quality of life MH Cullen, LJ Billingham, CM Woodroffe, AD Chetiyawardana, ... Journal of Clinical Oncology 17 (10), 3188-3194, 1999 | 565 | 1999 |
| Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas M Cullen, N Steven, L Billingham, C Gaunt, M Hastings, P Simmonds, ... New England Journal of Medicine 353 (10), 988-998, 2005 | 470 | 2005 |
| Addressing overtreatment of screen detected DCIS; the LORIS trial A Francis, J Thomas, L Fallowfield, M Wallis, JMS Bartlett, C Brookes, ... European journal of cancer 51 (16), 2296-2303, 2015 | 352 | 2015 |
| Identification of serum biomarkers for colon cancer by proteomic analysis DG Ward, N Suggett, Y Cheng, W Wei, H Johnson, LJ Billingham, T Ismail, ... British journal of cancer 94 (12), 1898-1905, 2006 | 301 | 2006 |
| Clinical development of new drug–radiotherapy combinations RA Sharma, R Plummer, JK Stock, TA Greenhalgh, O Ataman, S Kelly, ... Nature reviews Clinical oncology 13 (10), 627-642, 2016 | 280 | 2016 |
| Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer SA Hussain, R Ganesan, G Reynolds, L Gross, A Stevens, J Pastorek, ... British journal of cancer 96 (1), 104-109, 2007 | 255 | 2007 |
| Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane … JMS Bartlett, CL Brookes, T Robson, CJH van de Velde, LJ Billingham, ... Journal of clinical oncology 29 (12), 1531, 2011 | 234 | 2011 |
| Narrow‐band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder RT Bryan, LJ Billingham, DMA Wallace BJU international 101 (6), 702-706, 2008 | 234 | 2008 |
| Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial AM Young, LJ Billingham, G Begum, DJ Kerr, AI Hughes, DW Rea, ... The Lancet 373 (9663), 567-574, 2009 | 182 | 2009 |
| Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial MJ Calvert, N Freemantle, G Yao, JGF Cleland, L Billingham, JC Daubert, ... European heart journal 26 (24), 2681-2688, 2005 | 182 | 2005 |
| Methods for the analysis of quality-of-life and survival data in health technology assessment LJ Billingham, KR Abrams, DR Jones University of Leicester, 1999 | 180 | 1999 |
| Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data A Burton, LJ Billingham, S Bryan Clinical trials 4 (2), 154-161, 2007 | 178 | 2007 |
| Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers KJ Harrington, LJ Billingham, TB Brunner, NG Burnet, CS Chan, P Hoskin, ... British journal of cancer 105 (5), 628-639, 2011 | 171 | 2011 |
| Modelling prognostic factors in advanced pancreatic cancer DD Stocken, AB Hassan, DG Altman, LJ Billingham, SR Bramhall, ... British journal of cancer 99 (6), 883-893, 2008 | 155 | 2008 |
| European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial CA Hutchison, M Cook, N Heyne, K Weisel, L Billingham, A Bradwell, ... Trials 9, 1-7, 2008 | 143 | 2008 |
| Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative J Bogaerts, MR Sydes, N Keat, A McConnell, A Benson, A Ho, A Roth, ... European journal of cancer 51 (3), 271-281, 2015 | 142 | 2015 |
| Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial G Middleton, K Brock, J Savage, R Mant, Y Summers, J Connibear, ... The Lancet Respiratory Medicine 8 (9), 895-904, 2020 | 140 | 2020 |
| The National Lung Matrix Trial of personalized therapy in lung cancer G Middleton, P Fletcher, S Popat, J Savage, Y Summers, A Greystoke, ... Nature 583 (7818), 807-812, 2020 | 128 | 2020 |
| Radiofrequency-induced thermo-chemotherapy effect versus a second course of bacillus Calmette-Guérin or institutional standard in patients with recurrence of non–muscle … WS Tan, A Panchal, L Buckley, AJ Devall, LS Loubière, AM Pope, ... European urology 75 (1), 63-71, 2019 | 125 | 2019 |
